Demonstration of potent lipid-lowering activity by a thyromimetic agent devoid of cardiovascular and thermogenic effects

Atherosclerosis

Volumn 126, Issue 1, 1996, Pages 53-63

  Stephan, Zouhair F ^a   Yurachek, Edna C ^a   Sharif, Robin ^a   Wasvary, Jong M ^a   Leonards, Kenneth S ^a   Hu, Chii Whei ^a   Hintze, Thomas H ^b   Steele, Ronald E ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Atherosclerosis; Cholesterol; Hypolipidemic; L T3; LDL; Thyromimetic

Indexed keywords

ANTILIPEMIC AGENT; CGS 26214; LIOTHYRONINE; LIOTHYRONINE RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOG; DRUG RECEPTOR BINDING; DRUG UPTAKE; HEART MUSCLE CELL; HYPERCHOLESTEROLEMIA; LIVER CELL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030603997     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05893-5     Document Type: Article

References (35)

1. [1] Kannel WB, Gordon T, Castelli WP. Role of lipids and lipoprotein fractions in assessing atherogenesis. The Framingham Study. Prog Lipid Res 1981;20:339.
2. [2] Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J Am Med Assoc 1984;251:365.
3. [3] Blum CB, Levy RI. Current therapy for hypercholesterolemia. J Am Med Assoc 1989;261:3582.
4. [4] Chait A, Bierman EL, Albers JJ. Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. J Clin Endocrinol Metab 1979;48:887.
5. 125I-low density lipoprotein in hypothyroidism and thyrotoxicosis. Clin Sci 1965;29:217.
6. [6] Thompson GR, Soytar AK, Spengel FA, Jahaw A, Gavin SJP, Myant NB. Defects of receptor mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA 1981;78:2591.
7. [7] Staels B, van Tol A, Chan L, Will H, Verhoeven G, Auwerx J. Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase and low density lipoprotein receptor in rats. Endocrinology 1990;127:1144.
8. [8] Ness GC, Zhao Z. Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats. Arch Biochem Biophys 1994;315:199.
9. [9] Buccino RA, Spann JR, Pool PE, Sonnenblick EH, Braunwald E. Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. J Clin Invest 1967;46:1669.
10. [10] Goodkind MJ, Dambach GE, Thyrum PT, Luchi RJ. Effect of thyroxine on ventricular myocardial contractility and ATPase activity in guinea pigs. Am J Physiol 1974;226:66.
11. [11] Morkin E, Flink IL, Goldman S. Biochemical and physiologic effects of thyroid hormone on cardiac performance. Prog Cardiovasc Dis 1983;25:435.
12. [12] Dillman WH. Diabetes and thyroid hormone induced changes in cardiac function and their molecular basis. Annu Rev Med. 1989;40:373.
13. [13] Pontecorvi A, Robbins J. The plasma membrane and thyroid hormone entry into cells. Trends Endocrinol Metab 1989;8:91.
14. [14] Klein, I. Thyroid hormone and the cardiovascular system. Am J Med 1990;88:631.
15. [15] Emmelot P, Bos CJ, van Hoeven RP, van Blitterswijk WJ. Isolation of plasma membranes from rat and mouse livers and hepatomas. In: Fleischer S and Packer R. (eds). Methods of Enzymology. New York: Academic Press, Vol. 31, Part A, 1974;75.
16. [16] Spindler BJ, MacLeod KM, Ring J, Baxter JD. Thyroid hormone receptors: binding characteristics and lack of hormonal dependency for nuclear localization. J Biol Chem 1975;250:4118.
17. [17] Jackowski G, Liew CC. Fractionation of rat ventrical nuclei. Biochem J 1980;188:363.
18. [18] Kovanen PT, Brown MS, Goldstein JL. Increased binding of low density lipoprotein to liver membranes from rats treated with 17α-ethinyl estradiol. J Biol Chem 1979;254:11367.
19. [19] Stephan ZF, Yurachek EC. Rapid fluorometric assay of LDL receptor activity by Dil-labeled LDL. J Lipid Res 1993;34:325.
20. [20] Bradford MM. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248.
21. [21] Janero DR, Burghardt D, Feldman D. Amphiphile-induced heart muscle cell (myocyte) injury: effects of intracellular fatty acid overload. J Cell Physiol 1988;137:1.
22. [22] Murayama M, Goodkind MJ. Effect of thyroid hormone on the frequency-force relationship of arterial myocardium from the guinea pig. Circ Res 1968;23:743.
23. [23] Snedecor GW, Cochran WG. Statistical Methods, 7th Ed. Ames, IA: Iowa Press, 1981;91.
24. [24] Underwood AH, Emmett JC, Ellis D, Flynn SB, Leeson PD, Benson GM, Novelli R, Pearce NJ, Shah VP. A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity. Nature 1986;324:425.
25. 125I-L-triiodothyronine from hepatic and heart nuclei in vivo: possible relationship to hormonal activity. Biochem Biophys Res Commun 1973;55:544.
26. 3 enantiomers. Endocrinology 1983;113:1236.
27. [27] Brent GA. The molecular basis of thyroid hormone action. New Engl J Med 1984;331:847.
28. [28] Darling DS, Carter RL, Yen PM, Welborn JM, Chin WW, Umeda PK. Different dimerization activities of α-and β-thyroid hormone receptor isoforms. J Biol Chem 1993;268:10221.
29. [29] Haba T, Sakai Y, Koizumi J, Miyamoto S, Mabuchi H, Takeda R. A case of heterozygous familial hypercholesterolemia associated with hyperthyroidism: effects of triiodothyronine on low-density lipoprotein receptor and cholesterol synthesis. Metabolism 1983;32:1129.
30. [30] Chait A, Kanter R, Green W, Kenny M. Defective thyroid hormone action in fibroblasts cultured from subjects with syndrome of resistance to thyroid hormones. J Clin Endocrinol Metab 1982;54:767.
31. [31] Barker SB. Mechanism of action of thyroid hormone. Physiol Rev 1951;31:205.
32. [32] Liverini G, Iossa S, Barletti A. Relationship between resting metabolism and hepatic metabolism: effect of hypothyroidism and 24 h fasting. Horm Res 1992;38:154.
33. [33] Silva JE. Hormonal control of thermogenesis and energy dissipation. Trends Endocrinol Metab 1993;4:25.
34. [34] Horst C, Hartmut R, Seitz HJ. Rapid stimulation of hepatic oxygen consumption by 3,5-di-iodo-L-thyronine. Biochem J 1989;261:945.
35. [35] Lanni A, Moreno M, Cioffi M, Goglia F. Effect of 3,3′-di-iodothyronine and 3,5-di-iodothyronine on rat liver mitochondria. J Endocrinol 1993;136:59.